BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23783552)

  • 1. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
    Dai Z; Jin Y
    Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
    Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
    Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
    Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
    J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
    Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
    Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
    Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
    J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
    Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
    Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.
    Zhang Q; Ying J; Zhang K; Li H; Ng KM; Zhao Y; He Q; Yang X; Xin D; Liao SK; Tao Q; Jin J
    Cancer Lett; 2007 May; 249(2):220-6. PubMed ID: 17029774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
    Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line.
    Jin Y; Tian X; Shang Y; Huang P
    Oncol Rep; 2008 Mar; 19(3):669-74. PubMed ID: 18288400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of MTUS1 in human colon tumors.
    Zuern C; Heimrich J; Kaufmann R; Richter KK; Settmacher U; Wanner C; Galle J; Seibold S
    Oncol Rep; 2010 Jan; 23(1):183-9. PubMed ID: 19956880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ; Durkin ME; Popescu NC
    Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
    Liu Y; Zhou J; Hu Y; Wang J; Yuan C
    Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
    Wong CM; Lee JM; Ching YP; Jin DY; Ng IO
    Cancer Res; 2003 Nov; 63(22):7646-51. PubMed ID: 14633684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.